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The complex transcriptional landscape of the
anucleate human platelet
Paul F Bray1*†, Steven E McKenzie1†, Leonard C Edelstein1, Srikanth Nagalla1, Kathleen Delgrosso2, Adam Ertel2,
Joan Kupper2, Yi Jing3, Eric Londin3, Phillipe Loher3, Huang-Wen Chen3, Paolo Fortina2† and Isidore Rigoutsos3*†

Abstract
Background: Human blood platelets are essential to maintaining normal hemostasis, and platelet dysfunction often
causes bleeding or thrombosis. Estimates of genome-wide platelet RNA expression using microarrays have provided
insights to the platelet transcriptome but were limited by the number of known transcripts. The goal of this effort was
to deep-sequence RNA from leukocyte-depleted platelets to capture the complex profile of all expressed transcripts.
Results: From each of four healthy individuals we generated long RNA (≥40 nucleotides) profiles from total and
ribosomal-RNA depleted RNA preparations, as well as short RNA (<40 nucleotides) profiles. Analysis of ~1 billion reads
revealed that coding and non-coding platelet transcripts span a very wide dynamic range (≥16 PCR cycles beyond
β-actin), a result we validated through qRT-PCR on many dozens of platelet messenger RNAs. Surprisingly, ribosomal-RNA
depletion significantly and adversely affected estimates of the relative abundance of transcripts. Of the known
protein-coding loci, ~9,500 are present in human platelets. We observed a strong correlation between mRNAs
identified by RNA-seq and microarray for well-expressed mRNAs, but RNASeq identified many more transcripts of lower
abundance and permitted discovery of novel transcripts.
Conclusions: Our analyses revealed diverse classes of non-coding RNAs, including: pervasive antisense transcripts to
protein-coding loci; numerous, previously unreported and abundant microRNAs; retrotransposons; and thousands of
novel un-annotated long and short intronic transcripts, an intriguing finding considering the anucleate nature of
platelets. The data are available through a local mirror of the UCSC genome browser and can be accessed at: http://
cm.jefferson.edu/platelets_2012/.
Keywords: Platelet, Transcriptome, Ribosomal RNA, Non-coding RNA, miRNA, Repeat elements, Antisense transcripts

Background
Platelets are circulating peripheral blood cells that emerge
from the human bone marrow to function as critical
components in basic physiological processes such as
hemostasis, wound healing, inflammation, angiogenesis
and the pathophysiology of tumor metastases. Platelets
that exhibit functional extremes convey a commensurate
increased risk for bleeding or thrombosis. Notably, the
propensity for such extremes has been shown to be
heritable [1-3]. Nonetheless, an understanding of the
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responsible genes and underlying mechanisms remains
limited to date. In this regard, genome wide association
studies (GWAS) have identified loci associated with platelet number, platelet volume and ex vivo platelet aggregation [4,5], but the effect sizes have been quite small.
Furthermore, most of the identified loci are not in proteincoding genomic regions. Thus, new approaches are needed
to query the repertoire of platelet transcripts.
The platelet transcriptome is a reflection of the megakaryocyte RNA content at the time of (pro)-platelet release, subsequent splicing events, selective packaging and
platelet RNA stability, and can provide important insights
into platelet biology [6]. Platelets are known to contain
messenger RNAs (mRNAs) and indeed most studies support a strong correlation between the platelet’s proteincoding transcriptome and its proteome [7,8]. Platelets also
include unspliced pre-mRNAs, rRNAs, tRNAs and
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microRNAs (miRNAs) [9-11]. Most platelet studies to
date have characterized the platelet transcriptome using
microarrays and SAGE [12-18]. A recent effort compared
human and mouse platelet transcriptomes with the help
of deep-sequencing of poly-adenylated, long RNA transcripts [10].
The emerging important roles that non-coding RNAs
(ncRNAs) play in a cell [19], their interactions with one
another and with protein-coding transcripts [20-25], and
the speed by which many categories of ncRNAs [26] burst
onto the scene suggests that their involvement in biological processes remains largely unexplored. This is particularly true of platelets where an accurate understanding
of the transcriptome has both biological (improved understanding of platelet protein translation and the mechanisms
of megakaryocyte/platelet gene expression) and clinical
(novel biomarkers of disease) relevance.
Because the content and properties of nuclear and
cytoplasmic transcripts vary [27-29], the anucleate human
platelet represents a unique model for characterizing
post-transcriptional gene expression. In light of the above,
we deep-sequenced a) a total RNA preparation, b) a
ribosomal-RNA depleted RNA preparation, and c) a short
RNA preparation for each of the four individuals. Our
results have been embedded in a local mirror of the UCSC
genome browser and can be examined interactively at
http://cm.jefferson.edu/platelets_2012/.

Results
We carried out transcriptome sequencing of total RNA
isolated from leukocyte-depleted platelet (LDP) preparations from four healthy adults (hereafter referred to as
1N1, 2N2, 3N3, 4N4). LDPs were prepared by density
centrifugation of citrated whole blood followed by immunodepletion of CD45+ leukocytes [11]. This preparation
yielded fewer than 1 leukocyte per 5 million platelets. For
each individual, we constructed three libraries: a) long
(≥ 40 nucleotides) total RNA, b) long RNA depleted of
rRNA, and c) short (< 40 nucleotides) RNA. All sequencing was carried out on an Applied Biosystems/Life Technologies (AB/LT) SOLiD™ system.
Read mapping across the genome

The reads from each of the 12 generated datasets were
mapped separately on each chromosome and strand of
the human genome (assembly hg19) using the BWA
program [30] and the protocol described in Methods.
The non-uniform coverage of protein-coding transcripts
by next generation sequencing reads has been documented before [31] and was encountered in our analysis as
well. Table 1 shows the average numbers of obtained
and mapped reads for each of the three library types
(long total, long rRNA-depleted, and short RNA). Notably, mitochondrial transcripts represented more than
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Table 1 Summary of uniquely mapped reads
Library

Sequenced
reads

Uniquely
mapped reads

Long, Total RNA

85,526,881

30,465,049 (35.6%)

Long, rRNA-depleted RNA

57,581,167

19,978,474 (34.7%)

Short RNA

104,965,977

32,433,513 (30.9%)

Shown are averages from platelet RNA for each library type and for all
subjects.

half of the uniquely mapped long reads (58.1% long
total, 65.1% long rRNA-depleted, 1.3% short), something
also encountered by other unbiased methods such as
SAGE [12].
Estimating the abundance of protein-coding transcripts in
platelets

We devised a scheme (see Methods) for estimating the
expression levels of protein-coding transcripts from RNAseq reads. To estimate transcript abundance, we normalized for transcript length and scaled using the expression
levels of the β-actin isoform with ENSEMBL identifier
ENST00000331789. This scheme was very effective (see
below) and provided us the ability to appropriately scale
expression within a read-set and to compare expression
levels across read-sets. This β-actin transcript was quite
abundant in platelets, present at approximately 15.0 ±
1.5 cycles of PCR containing the equivalent of 10 ng
of total RNA, and shows the least amount of variation
(± ~3%) across the analyzed samples (Additional file 1:
Table S1). Pairwise comparisons (Pearson correlation) of
our mRNA data after normalizing with GAPDH and two
additional stable platelet transcripts, PPBP and B2M,
revealed data virtually identical to those originally obtained
using ACTB. Notably, the isoforms of the housekeeping
gene GAPDH, which is often used as an expression
normalizer, exhibited a substantial expression variation
upon rRNA depletion (-70% to +130% depending on the
specific GAPDH transcript that was considered). It will be
important for future platelet RNAseq studies with larger
numbers of subjects to confirm these observations pertaining to the isoforms of these two commonly utilized platelet
“normalizers.”
We used the most abundant isoform among those
derived from an individual protein-coding gene to represent the gene. Figure 1 shows the number of proteincoding genes as a function of the level of normalized
expression. This approach revealed different estimates of
protein-coding genes that are present at a given level of
abundance between total and rRNA-depleted RNA preparations. The finding underscores that estimates of
expressed genes were more similar amongst different
subjects for high abundance genes (leftwards in Figure 1),
and that there was substantial inter-individual variation in
total transcript estimates when considering the less
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Figure 1 Estimates of platelet expressed mRNAs. A) Total RNA. B) rRNA-depleted RNA. The x-axis shows the RNA-seq read number in log2 ratios
normalized to β-actin; the y-axis shows the number of expressed mRNAs. The result for total RNA from donor 2 N2 is an outlier with lower abundances.

abundant genes (rightwards in Figure 1). Protein-coding
transcripts for each of the four samples whose expression
was supported by the RNA-seq data are shown in
Additional file 2: Table S2A (total RNA) and Additional
file 3: Table S2B (rRNA-depleted RNA). It is worth
stressing that our normalization scheme enabled us to
compare expression levels across all preparations.

RNA-seq vs. qRT-PCR

We sought to determine the correlation between our
RNA-seq normalization approach and qRT-PCR on the

same RNA samples. We queried 2 collections of genes:
1) 10 transcripts that exhibited a broad range (> 3 orders
of magnitude, i.e. more than 10 PCR cycles) of normalized
read counts, 6 of which are well-studied in platelets; and,
2) 89 transcripts for GPCR signaling proteins from a commercial platform, 19 of which were detected using both
RNA-seq and qRT-PCR. Figure 2 shows a very high
correlation (Pearson r-value of 0.7757 at a p-value
<0.0001) for transcripts detected by both methodologies,
indicating that our approach of estimating transcript abundance from RNA-seq data is accurate over a wide range of
transcript expression levels.
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Figure 2 Correlation of platelet mRNA levels assessed by
RNA-seq and qRT-PCR. ΔCt values obtained by qRT-PCR (y-axis)
were plotted against the log2-normalized transcript determined by
RNA-seq (x-axis). Both methods normalized to β-actin expression.
Transcripts were considered “present” in the qRT-PCR with a cycle
threshold of ≤35. RNA-seq transcripts were considered that were no
lower than a normalized log2 expression value of -15 (i.e., 15 PCR
cycles [≥ 1/32,768th] of β-actin expression). The transcript in the
right lower quadrant represents β2-microblobulin, which is
expressed at a higher level than β-actin. Black points derive from
microarray; red points were selected as known, representative
platelet genes.

RNA-seq vs. microarrays

We also compared protein-coding transcripts from RNAseq data with previously published microarray datasets of
the platelet protein-coding transcriptome [15,17,32]. The
three microarray datasets exhibited reduced pair-wise
correlation with one another, perhaps the result of a dependence on the used platform and differences in the
sample sources and preparations (Figure 3A). In contrast,
there is a high and significant pair-wise correlation among
the RNA-seq datasets (Figure 3B). In light of these observations, it is not surprising that there was less correlation
between any RNA-seq and any microarray set (Figure 3A).
Adverse impact of ribosomal-RNA depletion on the
estimates of mRNA abundance

Having established the appropriateness of our normalization scheme, we sought to determine the potential impact of the depletion of ribosomal RNAs on the estimate
of relative abundance of the various protein-coding transcripts. To this end, we computed the ratios of the normalized abundance of transcripts between the total and
the rRNA-depleted RNA preparations. In an effort to be
conservative, and based on the data in Figures 1 and 2, we

only considered protein-coding transcripts with an estimated abundance that was ≥ 2-10 times that of β-actin, and
kept only those whose absolute ratio value was ≥ 2× between the two preparations. Unexpectedly, the number of
affected protein-coding genes was high, ranging from 745
(sample 4N4) to 2,341 (sample 2N2) genes (Additional file
4: Table S3). Considering the stringency of our criteria,
the true number of affected protein-coding transcripts is
very likely higher. These findings suggest that the ribosomal RNA depletion step adversely and extensively impacts
the relative abundance of protein-coding transcripts
within a sample and, by extension, the accurate estimate
of the transcripts’ expression levels. The situation is
further aggravated by the fact that the magnitude of this
impact appears to be transcript-dependent and thus nonuniform: as can be seen from Additional file 4: Table S3,
the ratio of the normalized expression between the total
and rRNA-depleted preparations spans a wide spectrum
of values in all four samples. Of particular note are the
members of the RNA interference pathway DGCR8,
DROSHA, XPO5, DICER1, EIF2C1, EIF2C2, EIF2C3, and
EIF2C4 (Table 2): all of them exhibited large differences
(up to 32-fold) between the total and rRNA-depleted
preparations.
Enriched categories of platelet protein-coding transcripts

We generated the intersection of the expressed proteincoding transcripts across all four samples and ranked
them according to abundance. We processed separately
the total RNA and the rRNA-depleted preparation.
Using GORILLA [33] with the four ranked lists corresponding to each of the two preparations we calculated
GO term enrichments with an eye towards assessing
whether the platelet protein-coding transcriptome was
enriched for certain biological characteristics. Figure 4
shows the top-ranking functional annotation clusters for
the biological process category, the number of genes
sharing each term, and the associated p-value (log10).
As expected, biological process terms such as coagulation,
platelet degranulation, etc. were over-represented in the
platelet transcriptome and both preparations. Additional
analyses of GO terms pertaining to cellular compartment
and molecular function are shown in Additional file 1:
Figure S1A-H.
Platelet miRNAs

We also queried the presence of miRNAs in the platelet
transcriptome. Additional file 5: Table S4 shows the
complete set of miRNAs whose expression was supported
by the RNA-seq data for each of the four samples. The expression data were normalized with the help of SNORD44;
SNORD44 was selected because of its abundance and
observed general stability across very diverse tissues. The
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Figure 3 Correlation heatmap matrix for RNA-seq vs. microarray analysis of the platelet transcriptome. A) To compare the proteincoding transcripts as deduced from RNA-seq and previous microarray analyses (Affymetrix GeneChip and Illumina BeadChip) and also microarrays
with one another, we used a Spearman correlation computed from the union of protein-encoding genes (13,691 in all) that were represented on
at least one of the platforms. B) To compare the RNA-seq datasets with one another, we computed Pearson’s correlation between the genomic
transcript profiles obtained by each dataset. In both A) and B), each square lists the correlation coefficient value between the corresponding
profiles; also, the color-coding convention is the same in order to facilitate comparisons.

table reveals that the expression for hundreds of miRNAs
was ≥ 32 times higher than SNORD44, suggesting that the
platelet transcriptome is rich in miRNAs, a finding also
reported by Landry et al. [34]. Unique to our analysis is
that we distinguish between the two potential products of
a miRNA precursor, namely 5p and 3p, and examine each
product’s expression separately (Additional file 1: Figure
S2 explains why this is important).

this end, we used the pseudogene definitions contained
in Release 63 of the ENSEMBL database: this Release
lists 11,983 transcripts corresponding to 11,158 genes.
We found pseudogene loci to be highly enriched across
all four samples and in both the total and rRNA
depleted preparations (see Additional file 1: Table S5 for
details). Notably, the observed enrichment values mirrored one another across the preparations.

Pseudogenes

Repeat elements

In light of recent work highlighting the importance of
pseudogenes in regulating miRNA-mediated repression
of targeted mRNAs [20,21], we analyzed our sequenced
read sets for evidence of pseudogene transcription. To

We also focused on the repeat element category of
characterized transcripts. In particular, we computed
enrichment values for both sense and antisense transcripts for each of the 116 families of elements that are
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Table 2 rRNA depletion alters the relative quantities of
transcripts
Gene

Range of estimate ratios (log-scale)

DICER1

−1.35 to 2.23

DROSHA

−0.97 to 1.88

EIF2C1

−0.18 to 2.10

EIF2C2

−0.30 to 1.23

EIF2C3

−0.72 to 4.06

EIF2C4

−1.19 to 0.37

XPO5

−2.50 to 2.09

The range (in log2-units) of the observed ratio “normalized-gene-abundancein-total over normalized-gene-abundance-in-depleted” from four different
biological samples and for genes relevant for the RNA interference pathway.
Ratios were derived from pairs of total and depleted preparations generated
from the same biological sample.

recognized by RepeatMasker [35] and separately for each
of the four samples and the three preparations (total and
rRNA-depleted long RNA, short RNA) – a total of 12
sets. Additional file 1: Table S6 and Additional file 1:
Table S7 show that several repeat family loci give rise to
both long and short platelet RNA transcripts.
Other categories of non-coding RNAs

Recently, a novel class of long ncRNAs, the “long-intergenic
non-coding RNAs,” or lincRNAs for short, has received a
lot of attention [23,36]. LincRNAs number over a thousand
members, yet with the exception of a handful of reports
[37-39] they remain essentially uncharacterized. Our analysis of the sequenced reads did not reveal any enrichment
of the corresponding genomic loci.
Novel and uncharacterized intronic transcripts

Our work uncovered extensive evidence for the existence
of transcripts that originate in the introns of known
protein-coding genes. This is of particular significance considering that platelets lack a nucleus. For such an analysis it
is imperative to distinguish bona fide intronic regions from
well-characterized transcripts that are known to be colocated with the introns of protein coding genes. We
thus worked with unspliced messenger RNA sequences
after first having 'subtracted' all sense instances of the
following categories of transcripts: protein-coding and
non-protein-coding exons; all known repeat elements;
rRNAs; snoRNAs; miRNAs; and, lincRNAs. To this end we
used the annotations in Release 63 (June 30, 2011) of the
ENSEMBL database. We analyzed each of the four samples
and three preparations (total and rRNA-depleted long
RNA, short RNA) separately. For the long RNA read sets,
we considered intronic real estate if and only if platelet
reads covered a minimum of 100 consecutive nucleotides
and the covered region had an estimated abundance relatively to ACTB of 1:1024 (which is equivalent to a
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conservative dynamic range of not more than 10 PCR
cycles beyond ACTB). For the short RNA read sets, we only
considered platelet reads mapping to intronic real estate if
they were at least 30 nucleotides long and had an estimated
abundance relatively to SNORD44 of 1:64 (which is equivalent to a conservative dynamic range of not more than 6
PCR cycles beyond SNORD44). Given the high stringencies
of length and abundance, we accepted such a region if at
least one of the sequenced samples showed evidence for it.
Across the four samples and two long RNA preparations,
we found a total of 6,992 bona fide intronic regions that
give rise to currently uncharacterized long RNA transcripts
satisfying the above constraints. We also found an additional 1,236 bona fide intronic regions that give rise to currently uncharacterized short RNA transcripts satisfying the
above constraints. Notably, these two collections of intronic
regions had only 18 members in common suggesting that
the two novel populations of (long and short) uncharacterized bona fide intronic transcripts originate from distinct
genomic loci. Additional file 6: Table S8 lists the genomic
coordinates for these two groups of intronic regions.
Novel and pervasive antisense transcripts

Our analysis also revealed the presence of a substantial
number of long and short platelet transcripts that were
antisense to known miRNAs, known protein-coding
exons, and notably, to known repeat element families.
For the miRNA analysis, we processed separately the
four read sets from the short RNA preparation. For the
protein-coding transcript analysis, we processed separately the eight read sets from the total and rRNAdepleted preparations. For the repeat element analysis,
we processed all read sets separately for each of the
four sequenced individuals. The following are the 10
miRNA precursors with previously unreported antisense
transcripts: hsa-miR-33b, hsa-miR-101, hsa-miR-191, hsamiR-219-2, hsa-miR-374b, hsa-miR-486, hsa-miR-625,
hsa-miR-766, hsa-miR-3135b, and hsa-miR-4433. The
short platelet RNAs we observed had lengths typical of a
miRNA and were transcribed from the strand opposite of
that of the known miRNA precursor. Each of the loci
listed above generated one or two distinct antisense transcripts, presumably a mature miRNA and its “star”
miRNA. There was also a high prevalence of transcripts
that were antisense to known protein-coding regions of
the genome. Table 3 shows the enrichment in such antisense transcripts that overlap the 50UTRs, 30UTRs or fulllength exonic space of known protein-coding transcripts.
Enrichment values are notable, independently of whether
we computed them in terms of span (which ignores the
number of reads sequenced from a genetic locus) or in
terms of support (which takes into account the number
of reads sequenced from a genetic locus). Unexpectedly,
our analyses revealed notable enrichment in both long
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Figure 4 Gene Ontology (GO) analysis of the platelet transcriptome by RNA-seq. Top-ranking biological processes by gene number
(panels A and C) and by categories (panels B and D) that emerge from a GORILLA analysis of those protein-coding transcripts common to the
four sequenced individuals. GO terms and p-values were computed and are shown separately for the total RNA (panels A and B) and the rRNAdepleted preparations (panels C and D). Note that the GO category of "coagulation" includes all aspects of platelet biology. See also Figure S1.

and short platelet RNAs that were antisense to several
known repeat families. Table 4 shows these enrichments
for the sequenced short platelet RNA-omes. Additional
file 1: Table S9 shows the corresponding values for the
long platelet RNA-omes and separately for the total and
rRNA-depleted preparations.
'Orphan' reads

We use the characterization ‘orphan’ to refer to those
RNA-seq reads that could not be mapped on the human
genome using our default parameter settings. To ensure
that we exhausted the possibilities, and in an effort to
address the potential identities of unmapped transcripts,
we conducted additional read mapping with alternative
computational settings and using curated datasets.
First, and in light of recent reports of extensive editing
of RNA transcripts [40] we used the BWA algorithm
[30] with higher-than-default sensitivity settings: in particular, we permitted up to six mismatches in the context of BWA’s length-dependent scheme for allowing
mismatches. We used this lenient parameter setting for
both the total and rRNA-depleted preparations (8 sets of
reads in total). In each case, we were able to map an
additional approximately four million reads (~6.5% of
the original set of sequenced reads). Additional file 1:
Table S10 provides relevant detailed statistics.

Since we used the full genome’s sequence to map the
sequenced reads the formal possibility remains that perhaps a significant portion of the orphan reads originate
from the exon-exon junctions of spliced protein-coding
transcripts. Thus, our subsequent investigation used the
598,379 exons listed in Release 63 of ENSEMBL to combinatorially enumerate all possible exon-exon junctions
using the known, non-overlapping exons of all 51,055
protein-coding and non-protein-coding genes contained
in the Release. This gave rise to 12,382,819 junctions on
which we attempted to map the orphan reads. Across all
read sets that were sequenced from the total RNA preparations, an average of 185,026 reads were mapped
onto the exon-exon junction set. The corresponding
number for the sets obtained from the rRNA-depleted
preparations was 191,736 reads. In both cases, only a
very small fraction of the reads mapped to exon-exon
junctions.
Lastly, we examined the possibility that the orphan reads
originate from the highly polymorphic human leukocyte
antigen (HLA) region of chromosome 6. To this end, we
used the 6,944 sequences contained in Release 3.5 of the
IMGT/HLA database [41,42] and searched them with
BWA and standard settings. An average of 5,601 (total
RNA) and 5,564 (rRNA-depleted RNA) reads were
mapped to this region suggesting that transcripts from the
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Table 3 Long platelet RNAs antisense to protein-coding sequences
Total RNA (span enrichment)

rRNA depleted (span enrichment)

region

sample 1

sample 2

sample 3

sample 4

sample 1

sample 2

sample 3

sample 4

50UTR

28.28

39.21

34.20

13.53

33.33

40.21

33.32

12.59

0

3 UTR

53.87

64.88

52.59

23.54

64.18

62.58

55.78

21.51

Exons

52.65

69.80

59.73

24.01

56.53

66.36

59.95

21.46

region

sample 1

sample 2

region

sample 1

sample 2

region

sample 1

5 UTR

2.89

4.22

6.29

3.79

6.02

4.32

11.94

9.35

30UTR

7.77

8.87

8.86

7.24

17.61

7.41

21.97

12.57

Exons

11.09

11.32

12.06

8.61

14.88

8.84

25.31

13.20

Total RNA (support enrichment)
0

rRNA depleted (support enrichment)
sample 2

Enrichment values are shown for the four samples and for sequenced long transcripts that are antisense to the 50UTRs, 30UTRs or full-length exons of known
protein-coding transcripts. For comparison purposes, we report span enrichment and support enrichment values, separately for the total and rRNA-depleted
preparations. Note the consistency of the enrichment across the four subjects and the two preparations.

HLA regions do not contribute in any significant manner
to the platelet transcriptome.
Data Access

Results have been embedded in a local mirror of the
UCSC genome browser and can be examined interactively at http://cm.jefferson.edu/platelets_2012/.
The data set supporting the results of this article is
available in the NCBI/GEO repository, accession number
SRA062032, http://www.ncbi.nlm.nih.gov/sra. The data
sets supporting the results of this article are included
within the article and its additional files.

Discussion
The cellular transcriptome

A prominent lesson that has emerged from the 1000
Genomes Project is the greater genetic variation in the
population than previously appreciated. Transcriptomics
is rapidly assuming a more prominent role in the understanding of basic molecular mechanisms accounting for
variation within the normal population and inherited
disease. We have sequenced RNA from the leukocytedepleted platelets of four healthy individuals and report
our findings from the analysis of the long and short
RNA transcript populations. In the case of long RNAs,
we carried out sequencing of both total and rRNAdepleted RNA. The generated data, accompanying genome browser, and data repository detail the totality of
RNA species present in the anucleate human platelet. We
are unaware of prior efforts that have provided as comprehensive a transcriptome evaluation of any human cell as
offered in our report. Our approach serves as a roadmap
for future transcriptome analyses and the findings have
important implications for the understanding of the transcriptome and the role of platelets in health and disease.
We utilized a distinct approach to the elucidation of
the platelet transcriptome that, as we discovered, exhibits an extraordinary complexity. Features of our

approach include: 1) the use of the anucleate platelet
that decouples the nuclear and cytoplasmic transcriptomes; 2) the use of total RNA and not poly-A enriched
RNA; 3) the use of a next generation sequencing platform (AB/LT SOLiD) that generated the high enough
read numbers needed to provide the required resolution
power; 4) the explicit evaluation of the impact of the
ribosomal RNA depletion step prior to sequencing; 5) an
enhanced mapping protocol that ensured exhaustive
mapping of the sequenced reads on the un-masked
human genome and the exclusion of reads that could
not be mapped uniquely; and, 6) the explicit search for
the presence or absence of RNA species that either have
not been previously discussed in the context of platelet
biology or that are not currently annotated in the public
databases. Findings from our analyses reveal a much more
diverse platelet transcriptome than previously appreciated,
and include pseudogenes, repeat elements, bona fide
intronic transcripts, novel short and long RNAs, transcripts antisense to exons and antisense to miRNAs. Our
data are publicly available and can be explored interactively through our local mirror of the UCSC genome
browser at http://cm.jefferson.edu/platelets_2012/.
The platelet context

Blood platelets originate from bone marrow precursor
megakaryocytes. As such, most platelet RNA results
from the transcription of nuclear DNA in the megakaryocyte, and thus reflects the status of the megakaryocyte
at the time of platelet release into the circulation. Notably, megakaryocytes from human bone marrow are neither routinely nor easily accessible for biological studies.
Megakaryocyte gene transcription responds to numerous
normal physiologic and pathologic stimuli. Additionally,
anucleate platelets are known to engage in both posttranscriptional processing of RNA and translation of
mRNA into protein, in response to external factors [9,43].
Consequently, the platelet transcriptome represents a
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Table 4 Short platelet RNAs antisense to repeat elements

sample 1 / Short

sample 3 / Short

Repeat family

Span
enrichment

DNA?.DNA?

2.08

sample 2 / Short

Repeat family

Span
enrichment

LTR?.LTR?

2.88

SINE.SINE

2.05

tRNA.tRNA

2.38

LINE.Dong-R4

1.85

DNA?.DNA?

2.00

SINE?.SINE?

1.82

LINE.Dong-R4

1.95

LTR.ERVL?

1.80

snRNA.snRNA

1.76

tRNA.tRNA

1.79

SINE?.SINE?

1.75

LINE.RTE-BovB

1.73

Satellite.acro

1.70

SINE.tRNA

1.64

SINE.SINE

1.64

rRNA.rRNA

1.62

Unknown.Unknown

1.63

snRNA.snRNA

1.62

scRNA.scRNA

1.62

DNA.hAT-Blackjack

1.60

LTR.ERVL?

1.59

DNA.TcMar-Mariner

1.60

DNA.Merlin

2.68

Unknown?.Unknown?

2.35

sample 4 / Short

SINE.tRNA

1.57

LTR.LTR

1.55

DNA.hAT-Blackjack

1.53

LINE.L1?

2.72

tRNA.tRNA

2.49

LTR?.LTR?

2.14

DNA.Merlin

2.40

LINE?.Penelope?

2.02

SINE?.SINE?

2.09

LINE.Dong-R4

1.95

LINE.RTE-BovB

2.02

tRNA.tRNA

1.83

SINE.tRNA

1.96

scRNA.scRNA

1.78

LTR?.LTR?

1.88

SINE.SINE

1.74

rRNA.rRNA

1.87

LTR.ERVL?

1.72

DNA?.DNA?

1.79

SINE.tRNA

1.69

Unknown.Unknown

1.71

DNA?.DNA?

1.66

LINE.Dong-R4

1.69

rRNA.rRNA

1.65

SINE.SINE

1.64

DNA.PiggyBac?

1.65

Unknown?.Unknown?

1.56

snRNA.snRNA

1.62

snRNA.snRNA

1.55

SINE.Deu

1.60

DNA.hAT-Blackjack

1.54

LTR.LTR

1.59

LTR.LTR

1.54

Unknown.Unknown

1.58

DNA.hAT-Blackjack

1.55

LINE.RTE-BovB

1.54

DNA.TcMar-Mariner

1.52

Enrichments values are shown for the four samples and for sequenced short transcripts that are antisense to known categories of repeat elements. Note the
prevalence of antisense transcripts to tRNAs, LINEs, SINEs and DNA transposons. All values represent span enrichments. The use of a question mark (“?”) next to a
repeat family category is inherited from RepeatMasker’s notation convention and indicates that the corresponding sequences are likely members of the stated
repeat family as per RepeatMasker’s analysis.

critical proxy biomarker of both megakaryocyte activity
and of the hemostatic, thrombotic, and inflammatory
challenges to the organism. These properties in conjunction with the rapidly emerging appreciation of the role of
non-coding RNAs in post-transcriptional processing and

translation make an inventory of the platelet RNA-ome
both timely and important.
Compared to other RNA-evaluating technologies, the
current limitations of RNA-seq in general and as applied
to platelets are the expense and the need for sophisticated
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computational analyses that have not yet been standardized or made widely available. As experience with the
method progresses and prices drop, these limitations will
be offset by the advantages of superior dynamic range, the
discovery of novel transcripts, and the simultaneous
assessment of expression levels, sequence variants and
splice variants, none of which can be achieved using conventional probe-based transcript analysis. A direct digital
detection technology (referred to as “Nanostring”) [44]
offers the advantage of requiring less starting material,
which can be limiting in platelet RNA studies, but this
technology is only available for profiling known miRNAs
or limited sets of known mRNAs. Of course, any RNA
transcriptome analysis must be considered in the context
of potential differences with megakaryocytes. Recently,
platelet RNA-seq successfully revealed abnormal splicing
events in 1) NBEAL2, thus identifying the gene responsible for the Gray Platelet Syndrome [45], and, 2) the
RNA-binding protein RBM8A, thus uncovering the gene
responsible for the TAR (=thrombocytopenia and absent
radii) syndrome [46]. Our data will serve as an early and
comprehensive reference and resource for other investigators wishing to understand better the normal platelet
transcriptome when searching for disease-producing transcript variants. Furthermore, it will serve as a much
needed “parts list” of platelet RNAs in the context of
studies of RNA-RNA and RNA-protein regulatory interactions. The absence of active transcription makes the platelet an attractive cell type for elucidating and deciphering
such higher order regulatory couplings.
RNA-seq is highly sensitive and capable of detecting
variability between samples caused by biological differences, technical variation, or environmental influence
during sample handling. The samples in our study were
processed using a methodology with excellent reproducibility [47] that minimizes technical and environmental
factors, and that was able to discover novel genetic and
transcriptomic variants regulating platelet biologic function [11,48,49]. However, additional platelet RNA-seq
data and analyses from a larger number of subjects is
needed to assess the relative contribution of biological
versus technical factors contributing to the observed transcript variation.
It is difficult to compare and contrast our study with
that of Rowley et al. [10] because of key differences in design, and in the technical and analytic approach. A particular value of the Rowley study is the comparison of
human and mouse platelet transcriptomes, which noted
some unexpected differences. However, Rowley et al. did a
single sequencing run on a pool of 2 human donors,
whereas we separately sequenced and provide profiles of
long total RNA, long rRNA-depleted RNA, and, short
RNA from 4 subjects. The larger number of samples,
an increased sequencing granularity, a normalization
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scheme that allows comparisons and assessment of interindividual variation, and a wide-ranging analysis of the
culled RNA-omes (both protein-coding and non-coding)
represent key elements of our work. Additionally, our use
of the industry-standard UCSC genome browser for visualizing our data will enable faster access and dissemination
of our results.
The findings
Validity of the approach

Comparison of our data to microarray results, both ours
and those in the public databases, showed RNA-seq to
have significant correlation with microarray for the subset of abundant protein-coding RNAs. GO analyses indicated that the expressed mRNAs were enriched in terms
such as coagulation, platelet degranulation, secretion,
cytoskeletal dynamics, receptor binding and G-protein
signaling. These analyses validate and support RNA-seq
and our analytic approach as appropriate for assessing
the platelet transcriptome.
The number of protein coding transcripts

In this work we confirm and, more importantly, extend
earlier platelet transcriptome studies by us and others
[10-12,15] in unanticipated ways. Prior platelet work
estimated the number of protein-coding transcripts to
between 1,500 and 9,000. These earlier efforts neither
emphasized nor appreciated the notion that such a count
is somewhat of a “moving target.” Our analyses of the
RNA-seq data clearly demonstrate that such an estimate
and the ability to do cross-sample comparisons depend
upon 1) the resolution ability of the used sequencing platform, 2) the read mapping criteria (e.g., use of uniquely
mapping reads), and 3) the used “read count” threshold.
Within 16 PCR cycles of β-actin, we find ~9,000 mRNAs
in the platelets of 4 healthy donors. Relaxed or more stringent criteria provide higher or lower estimates, respectively (Figure 1).
Ribosomal RNA depletion

Depletion of ribosomal RNA is considered a standard
approach in RNA-seq studies of nucleated cells. Driving
the choice is the observation that rRNA makes up ~7580% of the total amount of cellular RNA. To the best of
our knowledge, the impact of rRNA depletion has not
been previously studied, certainly not in the context of
platelet transcriptome analyses. Importantly, we found
that rRNA depletion strongly and adversely impacts the
characterization of platelet protein coding transcripts.
Indeed, rRNA depletion resulted in variations in abundance estimates that confounded meaningful analyses
across samples. Neither we nor others in the field have
ascertained the underlying mechanism by which rRNA
depletion alters relative mRNA abundances. Our finding
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does not appear to be a non-specific artifact: not only is
the dynamic range of the observed impact very significant but the number of the affected mRNAs is large. In
previous work, several authors noted that platelets dock
mRNAs to ribosomes and that this process can be selective for features of specific mRNAs [50,51], so it is
conceivable that the observed impact of rRNA depletion
on mRNA abundance is a platelet-specific event.
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it is possible that intergenic RNAs or transcripts with
retained introns are not functional in platelets, there is
accumulating evidence that intronic regions likely play rather involved and functionally significant roles in a cell
[53-58]. These reports, in conjunction with the data that
we have generated, and together with other accounts
whereby specific intronic transcripts have been associated
with some diseases [45,46] suggest that our resource will
be useful reference material for platelet disorders.

Novel antisense transcripts

Our analyses unexpectedly revealed the existence of numerous transcripts that are antisense to previously annotated genomic regions. In particular, we discovered
consistent enrichment in RNAs that are antisense to the
exons of known protein-coding loci across the four
healthy donors. We also found enrichment in long
RNAs that are antisense to known repeat families. Notably, we found even more pronounced enrichment in
short RNAs that are antisense to many different repeat
families. Naturally occurring antisense transcripts are
important regulators of gene expression via interference
with translation, RNA masking, etc. [52], and our results
suggest the possibility of important, previously unappreciated roles of antisense transcripts in platelet biology.
Many more miRNAs

We also discovered a larger number of platelet miRNAs
than previously reported, and separately characterized and
reported on the two potential products that can be transcribed from a microRNA precursor. Importantly, for 10
miRNA loci, we found and report evidence of transcription of short, miRNA-like-in-length RNAs that are antisense to the known miRNA or its “star” species. Not only
are these miRNA antisense species not currently contained in miRBase, but to the best of our knowledge, they
have not been reported previously in the platelet context.
Intronic transcripts

An additional intriguing finding pertains to our identification of both short and long RNA transcripts that originate
from thousands of intronic DNA genomic regions and
are not currently annotated in the public repositories
as known non-protein-coding transcripts from proteincoding loci, miRNAs, ribosomal RNAs, tRNAs, repeat elements, etc. In particular, the intronic loci that give rise to
the sequenced long platelet RNAs are distinct from the
intronic loci that give rise to the sequenced short platelet
RNAs. It is important to stress that we required a minimum span of 100 nucleotides for those intronic regions
that gave rise to the un-annotated long RNAs and a minimum span of 30 nucleotides for those intronic regions
that gave rise to the un-annotated short RNAs. Such strict
criteria suggest that the actual sources of un-annotated
intronic platelet transcripts are more numerous. Although

Transcripts from repeat elements and pseudogenes

One of the unexpected findings that emerged from our
work and analyses is the pervasive presence of long and
short RNAs that are both sense and antisense to the genomic locations of many families of repeat elements, and
nearly all known pseudogenes. The presence of expressed
repeat elements per se is not new and has been reported
previously, e.g. [59-61]. Additionally, many reports have
already provided evidence of significant connections between repeat elements and cellular processes in health and
disease [62-66]. However, there are several novel and interesting elements that emerged from our analyses and warranted reporting. First, we observed that there were
specific categories of repeat elements that were present in
our profiles. Second, the present categories seemed to have
consistent enrichments across the sequenced individuals.
Lastly, the consistency in the profiles among individuals despite the absence of transcriptional activity - fuels the
hypothesis that these repeats are of potential functional
significance in the platelet context. However, the considerable numbers of repeat elements and the relative diversity
of their categories make it difficult to conjecture what their
roles may be. Indeed there is a large number of possibilities that include: the possible formation of endogenous
siRNAs or small non-coding RNAs as previously described
[67,68]; the possible production of currently unsuspected
miRNAs [69,70]; the creation of substrates for miRNA targeting that could then acts as “decoys,” i.e. as competing endogenous RNAs (ceRNAs) that regulate mRNAs
[20-22,71,72]; their involvement in previously unrecognized
regulatory mechanisms [73-75]; etc. It is also important to
note that the observed repeat expression in platelets
appears to be ‘marshalled’ and unlike the aberrant expression that has been reported in human cancers [66].

Conclusion
Our work has revealed a highly complex transcriptional
landscape for the anucleate human platelet. The richness
and diversity of the present RNA molecules suggests a
context where platelet biology transcends protein- and
miRNA-centric descriptions. By making available our
findings we aim to facilitate the elucidation of previously
unappreciated molecular species and molecular interactions. This will eventually permit an improved understanding
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of the molecular mechanisms that regulate platelet physiology
and contribute to serious disorders of thrombosis, hemostasis,
and inflammation.

Methods
RNA preparation and RNA-seq

The study was approved by the Institutional Review
Board of Thomas Jefferson University, and informed
consent was obtained from all participants. Highly purified, leukocyte-depleted platelet (LDP) preparations were
obtained as previously described [11]. RNA extraction
was performed with TRIzolW (Invitrogen, Carlsbad, CA)
and RNA quality was assessed by the Agilent bio-analyzer
PICO chip. In some experiments, 2 μg of total RNA was
depleted of large 18S and 28S rRNA as well as 5S and 5.8S
using the RiboMinus Eukaryotic Kit (Invitrogen), which
uses biotinylated probes designed against these rRNAs
(following the manufacturer‘s protocol). Total RNA and
rRNA-depleted RNA were fragmented using RNAse III
digestion for 13 min in a 10 μl reaction containing 1 μl
of 10X RNAse III buffer and 20 U of RNAse III. After incubation the RNA was purified using the RiboMinus
Concentration Module (Invitrogen), and the size and yield
of RNA was determined using the Agilent bio-analyzer
PICO chip. Library construction, emulsion PCR, workflow
analysis and sequencing runs were performed following
standard AB/Life Technologies protocols. A typical sequence run generated ~100 million reads of 50 nt each for
long RNA and 30 nt long for short RNA, with the “strandedness” of the read on genomic DNA preserved.
Read mapping

Sequenced reads were mapped onto the human genome
assembly hg19 using the Burrows-Wheeler Alignment
(BWA) algorithm [30]. Reads sequenced from the short
RNA preparation were pre-processed using the cutadapt
utility [76]. During mapping, all reads were qualitytrimmed using each read’s associated quality values.
Also, we allowed up to 2 mismatches in each read using
BWA’s internal adaptive, read-length-dependent scheme.
We did not allow any insertions or deletions. All reads
that were mapped to the genome were post-processed,
and those that landed on multiple locations (whether on
the same or different chromosomes) were discarded
and excluded from further consideration. The uniquely
mapped reads can be examined at http://cm.jefferson.edu/
platelets_2012/ by navigating to the genomic locus of
interest; reads mapped to the forward strand are shown in
blue, and reads mapped to the reverse strand in red.
Estimating expression levels for transcripts

For each protein-coding transcript T, we determined the
number of reads that uniquely mapped to T’s exons; distinct sequenced reads that mapped to the same genomic/
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exonic location of T were counted multiply. We defined
the normalized expression (neT) of T by the ratio (cT/LT)/
(cβ-actin/Lβ-actin), where cT was the read count for T, cβ-actin
was the read count for the β-actin transcript, and LT and
Lβ-actin were the respective lengths of each transcript. For
genes with multiple known protein-coding transcripts, the
gene was assigned the neT value of its most abundant transcript. As described in the Results, we established that
β-actin mRNA is abundantly and consistently expressed
across samples. Throughout this study, we used the β-actin
transcript with ENSEMBL identifier ENST00000331789
and the relationship of neT to that of neENST00000331789
to determine the presence or absence of protein-coding
transcript T and, by extension, of the expression of the
parent gene.
For non-coding transcripts, we used the same approach but instead of β-actin we used the levels of the
small nucleolar RNA SNORD44 as reference. This
choice was informed by the abundance and apparent
stability of SNORD44’s expression across many tissues
and cell lines [77].
Quantitative Reverse Transcription PCR (qRT-PCR) of Gene
Expression

One microgram total RNA was reverse transcribed and
1% of the resulting cDNA (equivalent to 10 ng starting
RNA) was used in the PCR. Quantitative reverse transcriptase PCR (qRT-PCR) results using primers specific
for known platelet genes and for a panel of 89 genes encoding G-protein-coupled receptors are described in the
Supplement. mRNA levels were assessed by the 2-ΔΔCT
method normalized to β-actin [78].
Correlation between platelet RNA-seq and microarray
datasets

The average log2-normalized expression of each long total
RNA transcript across the 4 samples was ranked by transcript abundance and compared to published platelet
transcript profiles obtained on Affymetrix GeneChip [32]
and Illumina BeadChip microarray platforms [15,17]. A
Spearman’s correlation coefficient was computed for the
genes that are represented on all platforms.
Enrichment analysis

To characterize the human platelet transcriptome with regard to possible over-representation of transcripts of a
specific type, enrichment analysis was performed using
the coordinates of those RNA-seq reads from both long
and short total platelet RNA transcriptomes that could be
mapped on the genome and the genomic coordinates of
categories of transcripts as these are reported in the
ENSEMBL database.
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Additional file 1: Figure S1. Gene Ontology (GO) analysis of the
platelet transcriptome from total RNA by RNASeq. Figure S2. The
importance of distinguishing between the two products of a miRNA
precursor. Table S1. Optimal choice of transcript for normalizing proteincoding expression. Table S2. Protein-coding transcripts in each of the
four samples. Title and legend only Table S3. Impact of ribosomal RNA
depletion on the estimate of mRNA abundance. Title and legend only.
Table S4. MicroRNA transcripts in each of the four samples. Title and
legened only. Table S5. Pseudogene expression in platelets. Table S6.
Long platelet transcripts from repeat element regions. Table S7. Short
platelet transcripts from repeat element regions. Table S8. Coordinates
of protein-coding intronic regions that are not accounted for by the
available annotations in the public databases. Table S9. Long platelet
transcripts antisense to repeat element regions. Table S10. Mapping
statistics for very lenient settings.
Additional file 2: Table S2A. Protein-coding transcripts in each of the
four samples. List of the protein all coding transcripts whose expression
is supported by the collected RNA-seq data. List for the four total RNA
samples. In an effort to be conservative, and based on the data in Figures
1 and 2, we only considered protein-coding transcripts with an estimated
abundance that was ≥ 2-10 times that of β-actin, and kept only those
whose absolute ratio value was ≥ 2x between the two preparations.
Additional file 3: Table S2B. Protein-coding transcripts in each of the
four samples. List of the protein all coding transcripts whose expression
is supported by the collected RNA-seq data. List for the four rRNAdepleted samples. In an effort to be conservative, and based on the data
in Figures 1 and 2, we only considered protein-coding transcripts with an
estimated abundance that was ≥ 2-10 times that of β-actin, and kept only
those whose absolute ratio value was ≥ 2x between the two
preparations.
Additional file 4: Table S3. Impact of ribosomal RNA depletion on the
estimate of mRNA abundance. The table shows the base-2 logarithm of
the ratio of the normalized expression between the total and rRNAdepleted preparation, and for each of the four individuals that provided
the sequenced RNA. Only transcripts with an estimated abundance that
is ≥ 2-10 times that of β-actin (ENST00000331789) and whose normalized
expression differs by ≥ 2x (i.e. at least one log2 unit) between the
preparations are listed.
Additional file 5: Table S4. MicroRNA transcripts in each of the four
samples. List of all microRNAs whose expression is supported by the
collected RNA-seq data.
Additional file 6: Supplemental Materials. Genomic coordinates and
sequences of unannotated intronic regions that are found transcribed in
human platelets. These are culled from both the long and short RNA-seq
profiles.

Competing interests
The authors’ declare that they have no competing interests.
Authors’ contributions
PFB, SEM, PF, and IR conceived of the study, and participated in its design
and coordination. IR, PFB, PF, SEM, and LCE wrote the manuscript. LCE
participated in the design and coordination, and acquired and analyzed the
data. IR, H-WC, EL, PL, AE, and YJ acquired and analyzed the data. SN, KD,
and JK participated in the design and acquired data. All authors read and
approved the final manuscript.
Acknowledgments
We wish to thank Ms. Lin Ma and Dr. Xianguo Kong for excellent technical
assistance. This work was supported in part by the Cardeza Foundation for
Hematological Research (Philadelphia, PA; PFB. LCE, SEM), the Kimmel Cancer
Center (Philadelphia, PA; PF, KD, JK and AE), and by grants from the NIH-NCI
Cancer Center (P30-CA-56036 to PF, KD and AE), NIH-NHLBI (R01-HL-102482
to PB), NIH-NIAID (2U19AI056363-06/2030984 to IR), the William M. Keck
Foundation (IR) and TJU funds (IR, YJ, EL, PL, H-WC). The authors declare no
conflicts of interest.

Page 13 of 15

Author details
1
Cardeza Foundation for Hematologic Research, Division of Hematology,
Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
2
Cancer Genomics Laboratory, Kimmel Cancer Center, Thomas Jefferson
University, Philadelphia, PA, USA. 3Computational Medicine Center, Thomas
Jefferson University, Philadelphia, PA, USA.
Received: 28 June 2012 Accepted: 5 December 2012
Published: 16 January 2013

References
1. Jones CI, Garner SF, Angenent W, Bernard A, Berzuini C, Burns P, Farndale RW,
Hogwood J, Rankin A, Stephens JC, et al: Mapping the platelet profile for
functional genomic studies and demonstration of the effect size of the GP6
locus. Journal of thrombosis and haemostasis: JTH 2007, 5(8):1756–1765.
2. O'Donnell CJ, Larson MG, Feng D, Sutherland PA, Lindpaintner K, Myers RH,
D'Agostino RA, Levy D, Tofler GH: Genetic and environmental
contributions to platelet aggregation: the Framingham Heart Study.
Circulation 2001, 103(25):3051–3056.
3. Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Herrera-Galeano JE,
Wilson AF, Becker LC, Becker DM: Heritability of platelet function in
families with premature coronary artery disease. Journal of thrombosis
and haemostasis: JTH 2007, 5(8):1617–1623.
4. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, Lin SJ,
Kraja AT, Province MA, Yang Q, et al: Genome-wide meta-analyses
identifies seven loci associated with platelet aggregation in response to
agonists. Nat Genet 2010, 42(7):608–613.
5. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, SerbanovicCanic J, Elling U, Goodall AH, Labrune Y, et al: New gene functions in
megakaryopoiesis and platelet formation. Nature 2011, 480(7376):201–208.
6. Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA: Protein synthesis by
platelets: historical and new perspectives. Journal of thrombosis and
haemostasis: JTH 2009, 7(2):241–246.
7. Gnatenko DV, Perrotta PL, Bahou WF: Proteomic approaches to dissect
platelet function: Half the story. Blood 2006, 108(13):3983–3991.
8. McRedmond JP, Park SD, Reilly DF, Coppinger JA, Maguire PB, Shields DC,
Fitzgerald DJ: Integration of proteomics and genomics in platelets: a
profile of platelet proteins and platelet-specific genes. Molecular & cellular
proteomics: MCP 2004, 3(2):133–144.
9. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, Yost
CC, Rubner FJ, Albertine KH, Swoboda KJ, et al: Escaping the nuclear
confines: signal-dependent pre-mRNA splicing in anucleate platelets.
Cell 2005, 122(3):379–391.
10. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC,
Zimmerman GA, Weyrich AS: Genome-wide RNA-seq analysis of human
and mouse platelet transcriptomes. Blood 2011, 118(14):e101–111.
11. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J,
McKnight GS, Lopez JA, Yang L, et al: Platelet microRNA-mRNA
coexpression profiles correlate with platelet reactivity. Blood 2011,
117(19):5189–5197.
12. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF:
Transcript profiling of human platelets using microarray and serial
analysis of gene expression. Blood 2003, 101(6):2285–2293.
13. Kim HL: Comparison of oligonucleotide-microarray and serial analysis of
gene expression (SAGE) in transcript profiling analysis of megakaryocytes
derived from CD34+ cells. Exp Mol Med 2003, 35(5):460–466.
14. Gnatenko DV, Cupit LD, Huang EC, Dhundale A, Perrotta PL, Bahou WF:
Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases.
Distinct profiles predict the essential thrombocythemic phenotype.
Thromb Haemost 2005, 94(2):412–421.
15. Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q,
Whiteheart SW, Shaw C, et al: VAMP8/endobrevin is overexpressed in
hyperreactive human platelets: suggested role for platelet microRNA.
Journal of thrombosis and haemostasis: JTH 2010, 8(2):369–378.
16. Burns P, Gusnanto A, Macaulay IC, Rankin A, Tom B, Langford CF, Dudbridge
F, Ouwehand WH, Watkins NA: Identification of variation in the platelet
transcriptome associated with glycoprotein 6 haplotype. Platelets 2008,
19(4):258–267.
17. Goodall AH, Burns P, Salles I, Macaulay IC, Jones CI, Ardissino D, de Bono B,
Bray SL, Deckmyn H, Dudbridge F, et al: Transcription profiling in human

Bray et al. BMC Genomics 2013, 14:1
http://www.biomedcentral.com/1471-2164/14/1

18.

19.
20.

21.
22.

23.

24.

25.

26.
27.

28.

29.

30.
31.
32.

33.

34.

35.

36.

37.

38.

platelets reveals LRRFIP1 as a novel protein regulating platelet function.
Blood 2010, 116(22):4646–4656.
Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M,
Shi C, Zago AC, Garasic J, et al: Platelet expression profiling and clinical
validation of myeloid-related protein-14 as a novel determinant of
cardiovascular events. Circulation 2006, 113(19):2278–2284.
Shabalina SA, Spiridonov NA: The mammalian transcriptome and the
function of non-coding DNA sequences. Genome Biol 2004, 5(4):105.
Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP: A
coding-independent function of gene and pseudogene mRNAs
regulates tumour biology. Nature 2010, 465(7301):1033–1038.
Rigoutsos I, Furnari F: Gene-expression forum: Decoy for microRNAs.
Nature 2010, 465(7301):1016–1017.
Tay Y, Kats L, Salmena L, Weiss D, Tan SM, Ala U, Karreth F, Poliseno L,
Provero P, Di Cunto F, et al: Coding-independent regulation of the tumor
suppressor PTEN by competing endogenous mRNAs. Cell 2011,
147(2):344–357.
Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O,
Carey BW, Cassady JP, et al: Chromatin signature reveals over a thousand
highly conserved large non-coding RNAs in mammals. Nature 2009,
458(7235):223–227.
Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young
G, Lucas AB, Ach R, Bruhn L, et al: lincRNAs act in the circuitry controlling
pluripotency and differentiation. Nature 2011, 477(7364):295–300.
Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP: Conserved function of
lincRNAs in vertebrate embryonic development despite rapid sequence
evolution. Cell 2011, 147(7):1537–1550.
Esteller M: Non-coding RNAs in human disease. Nat Rev Genet 2011,
12(12):861–874.
Schwanekamp JA, Sartor MA, Karyala S, Halbleib D, Medvedovic M,
Tomlinson CR: Genome-wide analyses show that nuclear and cytoplasmic
RNA levels are differentially affected by dioxin. Biochim Biophys Acta 2006,
1759(8–9):388–402.
Clawson GA, Button JD, Liao YC, Smuckler EA: Cytoplasmic RNA
complementary to pre-albumin intron V. Biochem Biophys Res Commun
1986, 136(3):989–994.
Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F,
Ruskeepaa AL, Oresic M, Esau CC, Zdobnov EM, et al: Integration of
microRNA miR-122 in hepatic circadian gene expression. Genes Dev 2009,
23(11):1313–1326.
Li H, Durbin R: Fast and accurate short read alignment with BurrowsWheeler transform. Bioinformatics 2009, 25(14):1754–1760.
Srivastava S, Chen L: A two-parameter generalized Poisson model to
improve the analysis of RNA-seq data. Nucleic Acids Res 2010, 38(17):e170.
Lood C, Amisten S, Gullstrand B, Jonsen A, Allhorn M, Truedsson L, Sturfelt
G, Erlinge D, Bengtsson AA: Platelet transcriptional profile and protein
expression in patients with systemic lupus erythematosus: up-regulation
of the type I interferon system is strongly associated with vascular
disease. Blood 2010, 116(11):1951–1957.
Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z: GOrilla: a tool for
discovery and visualization of enriched GO terms in ranked gene lists.
BMC Bioinformatics 2009, 10:48.
Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P: Existence
of a microRNA pathway in anucleate platelets. NatStructMolBiol 2009,
16(9):961–966.
Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J:
Repbase Update, a database of eukaryotic repetitive elements. Cytogenet
Genome Res 2005, 110(1–4):462–467.
Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas
K, Presser A, Bernstein BE, van Oudenaarden A, et al: Many human large
intergenic noncoding RNAs associate with chromatin-modifying
complexes and affect gene expression. Proc Natl Acad Sci U S A 2009,
106(28):11667–11672.
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung
T, Argani P, Rinn JL, et al: Long non-coding RNA HOTAIR reprograms
chromatin state to promote cancer metastasis. Nature 2010,
464(7291):1071–1076.
Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M,
Curran M, Onder T, Agarwal S, et al: Large intergenic non-coding RNA-RoR
modulates reprogramming of human induced pluripotent stem cells.
Nat Genet 2010, 42(12):1113–1117.

Page 14 of 15

39. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough
LH, Helms JA, Farnham PJ, Segal E, et al: Functional demarcation of active
and silent chromatin domains in human HOX loci by noncoding RNAs.
Cell 2007, 129(7):1311–1323.
40. Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, Zhang K, Gao Y,
Church GM: Genome-wide identification of human RNA editing sites by
parallel DNA capturing and sequencing. Science 2009, 324(5931):1210–1213.
41. Robinson J, Malik A, Parham P, Bodmer JG, Marsh SG: IMGT/HLA database–
a sequence database for the human major histocompatibility complex.
Tissue Antigens 2000, 55(3):280–287.
42. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG: The IMGT/
HLA database. Nucleic Acids Res 2011, 39(Database issue):D1171–1176.
43. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N,
Grissom CK, Weyrich AS, Zimmerman GA: The septic milieu triggers
expression of spliced tissue factor mRNA in human platelets. J Thromb
Haemost 2011, 9(4):748–758.
44. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP,
Ferree S, George RD, Grogan T, et al: Direct multiplexed measurement of
gene expression with color-coded probe pairs. Nat Biotechnol 2008,
26(3):317–325.
45. Kahr WH, Hinckley J, Li L, Schwertz H, Christensen H, Rowley JW, Pluthero FG,
Urban D, Fabbro S, Nixon B, et al: Mutations in NBEAL2, encoding a BEACH
protein, cause gray platelet syndrome. Nat Genet 2011, 43(8):738–740.
46. Albers CA, Paul DS, Schulze H, Freson K, Stephens JC, Smethurst PA, Jolley
JD, Cvejic A, Kostadima M, Bertone P, et al: Compound inheritance of a
low-frequency regulatory SNP and a rare null mutation in exon-junction
complex subunit RBM8A causes TAR syndrome. Nat Genet 2012,
44(4):435–439.
47. Yee DL, Bergeron AL, Sun CW, Dong JF, Bray PF: Platelet hyperreactivity
generalizes to multiple forms of stimulation. J Thromb Haemost 2006,
4(9):2043–2050.
48. Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q,
Whiteheart SW, Shaw C, et al: VAMP8/endobrevin is overexpressed in
hyperreactive human platelets: suggested role for platelet microRNA.
J Thromb Haemost 2010, 8(2):369–378.
49. Edelstein LC, Luna EJ, Gibson IB, Bray M, Jin Y, Kondkar A, Nagalla S,
Hadjout-Rabi N, Smith TC, Covarrubias D, et al: Human genome-wide
association and mouse knockout approaches identify platelet supervillin
as an inhibitor of thrombus formation under shear stress. Circulation
2012, 125(22):2762–2771.
50. Plante I, Ple H, Landry P, Gunaratne PH, Provost P: Modulation of microRNA
Activity by Semi-microRNAs. Frontiers in genetics 2012, 3:99.
51. Zimmerman GA, Weyrich AS: Signal-dependent protein synthesis by
activated platelets: new pathways to altered phenotype and function.
Arterioscler Thromb Vasc Biol 2008, 28(3):s17–24.
52. Li K, Ramchandran R: Natural antisense transcript: a concomitant
engagement with protein-coding transcript. Oncotarget 2010, 1(6):447–452.
53. Bell TJ, Miyashiro KY, Sul J-Y, McCullough R, Buckley PT, Jochems J, Meaney
DF, Haydon P, Cantor C, Parsons TD, et al: Cytoplasmic BK(Ca) channel
intron-containing mRNAs contribute to the intrinsic excitability of
hippocampal neurons. Proc Natl Acad Sci U S A 2008, 105(6):1901–1906.
54. Buckley PT, Lee MT, Sul J-Y, Miyashiro KY, Bell TJ, Fisher SA, Kim J, Eberwine
J: Cytoplasmic intron sequence-retaining transcripts can be dendritically
targeted via ID element retrotransposons. Neuron 2011, 69(5):877–884.
55. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A,
Lagarde J, Lin W, Schlesinger F, et al: Landscape of transcription in human
cells. Nature 2012, 489(7414):101–108.
56. Li Y, Bor Y-C, Misawa Y, Xue Y, Rekosh D, Hammarskj√∂ld ML: An intron
with a constitutive transport element is retained in a Tap messenger
RNA. Nature 2006, 443(7108):234–237.
57. Louro R, El-Jundi T, Nakaya HI, Reis EM, Verjovski-Almeida S: Conserved
tissue expression signatures of intronic noncoding RNAs transcribed
from human and mouse loci. Genomics 2008, 92(1):18–25.
58. Tsirigos A, Rigoutsos I: Human and mouse introns are linked to the same
processes and functions through each genome's most frequent nonconserved motifs. Nucleic Acids Res 2008, 36(10):3484.
59. Belancio VP, Roy-Engel AM, Pochampally RR: Somatic expression of LINE-1
elements in human tissues. Nucleic Acids Res 2010, 38(12):3909–3922.
60. Faulkner GJ, Kimura Y, Daub CO, Plessy C, Irvine KM, Schroder K, Cloonan N,
Lassmann T, Waki K, Hornig N, et al: The regulated retrotransposon
transcriptome of mammalian cells. Nat Genet 2009, 41(5):563–571.

Bray et al. BMC Genomics 2013, 14:1
http://www.biomedcentral.com/1471-2164/14/1

61. Sasaki T, Nishihara H, Hirakawa M, Fujimura K, Tanaka M, Kokubo N, KimuraYoshida C, Matsuo I, Sumiyama K, Saitou N, et al: Possible involvement of
SINEs in mammalian-specific brain formation. Proc Natl Acad Sci U S A
2008, 105(11):4220–4225.
62. Cruickshanks HA, Tufarelli C: Isolation of cancer-specific chimeric
transcripts induced by hypomethylation of the LINE-1 antisense
promoter. Genomics 2009, 94(6):397–406.
63. Montoya-Durango DE, Ramos KS: L1 retrotransposon and retinoblastoma:
molecular linkages between epigenetics and cancer. Curr Mol Med 2010,
10(5):511–521.
64. Ohnishi Y, Totoki Y, Toyoda A, Watanabe T, Yamamoto Y, Tokunaga K,
Sakaki Y, Sasaki H, Hohjoh H: Active role of small non-coding RNAs
derived from SINE/B1 retrotransposon during early mouse development.
Mol Biol Rep 2011, 36:903–9.
65. Ramos KS, He Q, Kalbfleisch T, Montoya-Durango DE, Teneng I, Stribinskis V,
Brun M: Computational and biological inference of gene regulatory
networks of the LINE-1 retrotransposon. Genomics 2007, 90(2):176–185.
66. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ,
Contino G, Deshpande V, Iafrate AJ, Letovsky S, et al: Aberrant
Overexpression of Satellite Repeats in Pancreatic and Other Epithelial
Cancers. Science (New York, NY) 2011, 331:593–6.
67. Smalheiser NR, Lugli G, Thimmapuram J, Cook EH, Larson J: Endogenous
siRNAs and noncoding RNA-derived small RNAs are expressed in adult
mouse hippocampus and are up-regulated in olfactory discrimination
training. RNA 2011, 17(1):166–181.
68. Watanabe T, Totoki Y, Toyoda A, Kaneda M, Kuramochi-Miyagawa S, Obata
Y, Chiba H, Kohara Y, Kono T, Nakano T, et al: Endogenous siRNAs from
naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature
2008, 453(7194):539–543.
69. Yuan Z, Sun X, Liu H, Xie J: MicroRNA genes derived from repetitive
elements and expanded by segmental duplication events in mammalian
genomes. PLoS One 2011, 6(3):e17666.
70. Gu TJ, Yi X, Zhao XW, Zhao Y, Yin JQ: Alu-directed transcriptional
regulation of some novel miRNAs. BMC Genomics 2009, 10:563.
71. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M,
Tramontano A, Bozzoni I: A long noncoding RNA controls muscle
differentiation by functioning as a competing endogenous RNA.
Cell 2011, 147(2):358–369.
72. Smalheiser NR, Torvik VI: Alu elements within human mRNAs are probable
microRNA targets. Trends in genetics: TIG 2006, 22(10):532–536.
73. Modarresi F, Faghihi MA, Lopez-Toledano MA, Fatemi RP, Magistri M,
Brothers SP, van der Brug MP, Wahlestedt C: Inhibition of natural antisense
transcripts in vivo results in gene-specific transcriptional upregulation.
Nat Biotechnol 2012, 30(5):453–459.
74. Muro EM, Andrade-Navarro MA: Pseudogenes as an alternative source of
natural antisense transcripts. BMC Evol Biol 2010, 10:338.
75. Lin R, Roychowdhury-Saha M, Black C, Watt AT, Marcusson EG, Freier SM,
Edgington TS: Control of RNA processing by a large non-coding RNA
over-expressed in carcinomas. FEBS Lett 2011, 585(4):671–676.
76. Martin M: Cutadapt removes adapter sequences from high-throughput
sequencing reads. EMBnetjournal 2011, 17(1):10–12. Next Generation
Sequencing Data Analysis.
77. Wong L, Lee K, Russell I, Chen C: Endogenous Controls for Real-Time
Quantitation of miRNA Using TaqManW MicroRNA Assays. In Edited by
Biosystems A. Foster City: Applied Biosystems; 2007.
78. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2ΔΔCt method. Methods 2001,
25(4):402–408.
doi:10.1186/1471-2164-14-1
Cite this article as: Bray et al.: The complex transcriptional landscape of
the anucleate human platelet. BMC Genomics 2013 14:1.

Page 15 of 15

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

